Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment
| Errataetall: |
CommentOn: Ann Rheum Dis. 2018 Nov;77(11):1694-1695. - PMID 29776976 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Autoimmunity reviews - 18(2019), 3 vom: 19. März, Seite 312-314 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Emmi, Giacomo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 31.12.2019 Date Revised 31.12.2019 published: Print-Electronic CommentOn: Ann Rheum Dis. 2018 Nov;77(11):1694-1695. - PMID 29776976 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.autrev.2018.11.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM292677766 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM292677766 | ||
| 003 | DE-627 | ||
| 005 | 20231225073637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.autrev.2018.11.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0975.xml |
| 035 | |a (DE-627)NLM292677766 | ||
| 035 | |a (NLM)30639638 | ||
| 035 | |a (PII)S1568-9972(19)30012-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Emmi, Giacomo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.12.2019 | ||
| 500 | |a Date Revised 31.12.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ann Rheum Dis. 2018 Nov;77(11):1694-1695. - PMID 29776976 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Antiphospholipid antibodies | |
| 650 | 4 | |a B-cells | |
| 650 | 4 | |a Belimumab | |
| 650 | 4 | |a Hydroxychloroquine | |
| 650 | 4 | |a SLE | |
| 650 | 7 | |a Antibodies, Antiphospholipid |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Glycoproteins |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a belimumab |2 NLM | |
| 650 | 7 | |a 73B0K5S26A |2 NLM | |
| 700 | 1 | |a Bettiol, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Palterer, Boaz |e verfasserin |4 aut | |
| 700 | 1 | |a Silvestri, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Vitiello, Gianfranco |e verfasserin |4 aut | |
| 700 | 1 | |a Parronchi, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Prisco, Domenico |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Autoimmunity reviews |d 2002 |g 18(2019), 3 vom: 19. März, Seite 312-314 |w (DE-627)NLM126096996 |x 1873-0183 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2019 |g number:3 |g day:19 |g month:03 |g pages:312-314 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.autrev.2018.11.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2019 |e 3 |b 19 |c 03 |h 312-314 | ||